Características sociodemográficas y clínicas de la hiperplasia prostática benigna

Abstract

According to the World Health Organization (WHO), Benign Prostatic Hyperplasia (BPH) is considered the most common benign tumor in men, defined as the enlargement of the prostate gland, has an overall incidence of 40% which varies according to risk factors, adequate control is necessary because a timely diagnosis influences the treatment, which should be an individualized and therapeutic approach to reduce the possible morbidity and mortality. General Objective: To describe sociodemographic and clinical characteristics ofpatients with benign prostatic hyperplasia. Methodology: A descriptive, qualitative, prospective, longitudinal, prospective study was undertaken, focused on a bibliographic and systematic review including articles, practical guides from joumals such as Redalyc, Scielo, Cochrane. Use of Results: The results obtained will be used as a source of sustainable and synthesized information for subsequent use as a basis for more complex projects. Development: 68 articles were reviewed, with 52 elements for inclusion; 29 were excluded because they were not closely related to the specified criteria. Twenty-three articles met the established parameters. Conclusions: BPH is defined as the increase of smooth muscle and its transitional cells, the risk factors are age from 40 years, hormonal alterations, genetic factors, black race, obesity, among others, the clinic is related to the urination phase and obstructive and irritative symptomatology.